News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
317,754 Results
Type
Article (15767)
Company Profile (293)
Press Release (301686)
Multimedia
Podcasts (66)
Webinars (11)
Section
Business (91717)
Career Advice (165)
Deals (16218)
Drug Delivery (38)
Drug Development (53797)
Employer Resources (31)
FDA (6924)
Job Trends (5563)
News (165419)
Policy (12345)
Tag
Academia (965)
Accelerated approval (9)
Adcomms (14)
Allergies (75)
Alliances (26199)
ALS (100)
Alzheimer's disease (1025)
Antibody-drug conjugate (ADC) (167)
Approvals (7033)
Artificial intelligence (200)
Autoimmune disease (53)
Automation (9)
Bankruptcy (111)
Best Places to Work (4796)
BIOSECURE Act (6)
Biosimilars (86)
Biotechnology (235)
Bladder cancer (84)
Brain cancer (36)
Breast cancer (274)
Cancer (2475)
Cardiovascular disease (186)
Career advice (149)
Career pathing (4)
CAR-T (172)
CDC (5)
Cell therapy (468)
Cervical cancer (12)
Clinical research (45323)
Collaboration (894)
Company closure (2)
Compensation (471)
Complete response letters (31)
COVID-19 (1168)
CRISPR (73)
C-suite (378)
Cystic fibrosis (96)
Data (3061)
Denatured (13)
Depression (73)
Diabetes (222)
Diagnostics (1793)
Digital health (8)
Diversity (4)
Diversity, equity & inclusion (9)
Drug discovery (134)
Drug pricing (38)
Drug shortages (3)
Duchenne muscular dystrophy (182)
Earnings (35448)
Editorial (21)
Employer branding (4)
Employer resources (29)
Events (54327)
Executive appointments (612)
FDA (8353)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (5)
Frontotemporal dementia (13)
Funding (799)
Gene editing (145)
Generative AI (14)
Gene therapy (407)
GLP-1 (482)
Government (1244)
Grass and pollen (3)
Guidances (162)
Healthcare (7148)
HIV (12)
Huntington's disease (33)
IgA nephropathy (50)
Immunology and inflammation (149)
Immuno-oncology (9)
Indications (36)
Infectious disease (1259)
Inflammatory bowel disease (144)
Inflation Reduction Act (9)
Influenza (39)
Intellectual property (135)
Interviews (18)
IPO (8166)
IRA (12)
Job creations (1044)
Job search strategy (137)
Kidney cancer (8)
Labor market (17)
Layoffs (240)
Leadership (7)
Legal (2147)
Liver cancer (47)
Longevity (8)
Lung cancer (364)
Lymphoma (174)
Machine learning (17)
Management (7)
Manufacturing (297)
MASH (107)
Medical device (3572)
Medtech (3579)
Mergers & acquisitions (8615)
Metabolic disorders (604)
Multiple sclerosis (92)
NASH (13)
Neurodegenerative disease (145)
Neuropsychiatric disorders (45)
Neuroscience (1759)
NextGen: Class of 2025 (2142)
Non-profit (898)
Now hiring (27)
Obesity (266)
Opinion (113)
Ovarian cancer (103)
Pain (77)
Pancreatic cancer (116)
Parkinson's disease (188)
Partnered (11)
Patents (246)
Patient recruitment (212)
Peanut (40)
People (28812)
Pharmaceutical (47)
Pharmacy benefit managers (7)
Phase I (15661)
Phase II (20872)
Phase III (13623)
Pipeline (1766)
Policy (78)
Postmarket research (992)
Preclinical (6598)
Press Release (32)
Prostate cancer (117)
Psychedelics (47)
Radiopharmaceuticals (229)
Rare diseases (464)
Real estate (1890)
Recruiting (12)
Regulatory (10856)
Reports (22)
Research institute (996)
Resumes & cover letters (18)
Rett syndrome (13)
RNA editing (15)
RSV (14)
Schizophrenia (106)
Series A (145)
Series B (110)
Service/supplier (1)
Sickle cell disease (58)
Special edition (16)
Spinal muscular atrophy (118)
Sponsored (13)
Startups (2198)
State (1)
Stomach cancer (6)
Supply chain (31)
Tariffs (17)
The Weekly (52)
Vaccines (316)
Venture capital (45)
Weight loss (147)
Women's health (19)
Worklife (2)
Date
Today (2)
Last 7 days (349)
Last 30 days (1363)
Last 365 days (19234)
2025 (15025)
2024 (21853)
2023 (23966)
2022 (30248)
2021 (31137)
2020 (26588)
2019 (18341)
2018 (13441)
2017 (15637)
2016 (13739)
2015 (16811)
2014 (12453)
2013 (9313)
2012 (9526)
2011 (9706)
2010 (9313)
Location
Africa (202)
Alabama (58)
Alaska (2)
Arizona (65)
Arkansas (5)
Asia (30826)
Australia (4490)
California (5842)
Canada (1688)
China (674)
Colorado (202)
Connecticut (217)
Delaware (171)
Europe (45953)
Florida (729)
Georgia (181)
Hawaii (2)
Idaho (16)
Illinois (335)
India (28)
Indiana (138)
Iowa (7)
Japan (249)
Kansas (77)
Kentucky (7)
Louisiana (4)
Maine (13)
Maryland (682)
Massachusetts (4725)
Michigan (97)
Minnesota (233)
Mississippi (3)
Missouri (29)
Montana (14)
Nebraska (4)
Nevada (30)
New Hampshire (15)
New Jersey (1509)
New Mexico (12)
New York (1541)
North Carolina (736)
North Dakota (6)
Northern California (2714)
Ohio (150)
Oklahoma (11)
Oregon (23)
Pennsylvania (1090)
Puerto Rico (8)
Rhode Island (26)
South America (275)
South Carolina (6)
Southern California (2289)
Tennessee (32)
Texas (725)
United States (19863)
Utah (92)
Virginia (118)
Washington D.C. (37)
Washington State (488)
West Virginia (1)
Wisconsin (32)
317,754 Results for "alexo therapeutics ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tenpoint Therapeutics, Ltd. to Participate in Four Upcoming Investor Conferences
October 14, 2025
·
1 min read
Press Releases
Tenpoint Therapeutics, Ltd. to Participate in Investor Conferences in September 2025
August 25, 2025
·
1 min read
Press Releases
Tenpoint Therapeutics Ltd. to Participate in Upcoming Investor Conferences in August 2025
August 5, 2025
·
2 min read
Press Releases
Lobe Sciences Ltd. and Cynaptec Pharmaceuticals, Inc. to Present a New Therapeutic Approach for the Treatment of Chronic Cluster Headaches at Clusterbusters 2025
September 10, 2025
·
6 min read
Press Releases
Medicus Pharma Ltd. to Present at The Maxim Growth Summit 2025
October 14, 2025
·
10 min read
Press Releases
Tenpoint Therapeutics Ltd. Appoints Melissa Epperly as Chief Financial Officer
June 2, 2025
·
2 min read
Press Releases
Guided Therapeutics Makes Initial Shipment to New Chinese Distribution Partner Hangzhou Dongye Medical Technology, Ltd.
July 3, 2025
·
2 min read
Press Releases
Medicus Pharma Ltd. Completes Acquisition of Antev Limited
Antev is developing Teverelix, a next generation GnRH Antagonist, as a first in class market product for Acute Urinary Retention (AURr) and high CV risk Prostate Cancer collecting representing ~US$6 billion in potential market opportunityPatrick J. Mahaffy, a veteran pharma executive and the former Chairman of Antev, appointed to Medicus Board of Directors
September 2, 2025
·
10 min read
Press Releases
Faron Pharmaceuticals Ltd: Exercise of Options, Director Dealing and Issue of Equity
September 19, 2025
·
4 min read
Press Releases
Medicus Pharma Ltd. Announces $8.0 Million Non-Dilutive Debenture Financing
September 18, 2025
·
8 min read
1 of 31,776
Next
